You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普萊柯(603566.SH)業績快報:2020年淨利升98.32%至2.17億元
格隆匯 03-08 16:22

格隆匯 3 月 8日丨普萊柯(603566.SH)披露2020年度業績快報,實現營業總收入9.29億元,同比增長40.01%;歸屬於上市公司股東的淨利潤2.17億元,同比增長98.32%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.55億元,同比增長142.83%;基本每股收益0.68元。

2020年度,在產品研發與銷售方面,公司豬用疫苗銷量恢復顯著,禽用疫苗和化學藥品穩步增長;口蹄疫、禽流感等基因工程亞單位疫苗研發進展順利;普萊柯(南京)生物技術有限公司、中普生物製藥有限公司通過生物安全三級防護檢查驗收,取得GMP證書和產品批准文號,進入高致病性禽流感(H5+H7)、口蹄疫市場。在生產管理方面,公司以信息化建設實現管理升級。在資本運作方面,項目團隊保持跟進,穩步推進。

影響經營業績的因素主要為以下幾方面:公司下游生豬養殖企業積極復產,公司相關豬用疫苗及化藥產品市場整體向好;公司近期上市的基因工程及多聯多價疫苗獲市場高度認可,貢獻了較大的銷售增量;對大型養殖集團客户開發成效顯現,直銷業務收入佔比持續提升。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account